Stay updated with breaking news from Eqs Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
EQS Group-Ad-hoc: RELIEF THERAPEUTICS Holding AG / Key word(s): Patent Acer Therapeutics Receives Notice of Allowance of Key U.S. Patent Application Covering ACER-001 Formulation 07-Oct-2021 / 07:00
EQS Group-Ad-hoc: RELIEF THERAPEUTICS Holding AG / Key word(s): Legal Matter Relief Therapeutics Announces Filing of Lawsuit Against its U.S. Collaboration Partner, NeuroRx, Inc. and its CEO, Dr. Jonathan
EQS Group-Ad-hoc: RELIEF THERAPEUTICS Holding AG / Key word(s): Patent Acer Therapeutics Receives Notice of Allowance of Key U.S. Patent Application Covering ACER-001 Formulation 07-Oct-2021 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsibl...
EQS Group-News: Kudelski Group / Key word(s): Miscellaneous Kudelski Group Concludes a Technology and Intellectual Property License Agreement with AdidasTitle 07.10.2021 / 17:45 Cheseaux-sur-Lausanne
EQS Group-Ad-hoc: RELIEF THERAPEUTICS Holding AG / Key word(s): Miscellaneous/Miscellaneous Acer Therapeutics and Relief Therapeutics Announce FDA Acceptance for Filing of New Drug Application for